Navigation Links
Mylan Launches Thiamine Hydrochloride Injection
Date:6/28/2012

PITTSBURGH, June 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for preservative-free Thiamine Hydrochloride Injection, 100 mg/mL, packaged in 200 mg/2 mL multiple-dose vials. This product is indicated for the treatment of thiamine deficiency.

Thiamine Hydrochloride Injection, 100 mg/mL, had U.S. sales of approximately $18.6 million for the 12 months ending March 31, 2012, according to IMS Health. Mylan is shipping this product, presented in 25-vial packs, immediately.

Currently, Mylan has 169 ANDAs pending FDA approval representing $83.9 billion in annual sales, according to IMS Health. Thirty-seven of these pending ANDAs are potential first-to-file opportunities, representing $25.6 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around th
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  MiMedx Group, Inc. (NASDAQ: ... utilizing human amniotic tissue and patent-protected processes to ... the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, ... and corrected the multiple inaccuracies in the press ... regarding the recent rulings from the Patent Trial ...
(Date:8/27/2015)...  Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 16, 2015, ... to listen to the live discussion via the internet ... https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay of ... conclusion of the live event and accessible via the ...
(Date:8/27/2015)... 27, 2015 Major pharmaceutical and medical device companies ... conference in Philadelphia on Oct. 20, ... Tom Hagy of HB Litigation Conferences has announced. ... website at http://litigationconferences.com/?p=31886 The program is ... & Mahoney and Michelle Hart Yeary of Dechert ...
Breaking Medicine Technology:MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3
... Systems ( http://www.dcmsys.com ), healthcare IT company and teleradiology ... the Vendor Neutral Archive (VNA) vendor of choice by ... Dicom Systems, VNA works with any existing ... current storage to your PACS archive at any time, ...
... LANSING, Mich., Jan. 16, 2012  Neogen Corporation (NASDAQ: ... detect precise amounts of the mycotoxin zearalenone in grain ... wide variety of reproductive problems if eaten by livestock. ... to the company,s unequaled line of simple, quick, and ...
Cached Medicine Technology:ONRAD, Inc. Chooses Dicom Systems' Vendor Neutral Archive 2Neogen Develops Simple, Precise Test for Mold Toxin Zearalenone 2
(Date:8/27/2015)... ... 27, 2015 , ... In mid-May, Logistics Trust, Inc. (“Logistics ... launch of its Doobster platform, a HIPAA-compliant mobile application that allows medical marijuana ... phones and tablets. Well, Doobster, “The App That Delivers!” is here! ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Summit , scheduled for October 27-29, 2015 in San Jose, CA. The ... will primarily focus on the void that exists where battery development and energy ...
(Date:8/27/2015)... ... ... In addition to its existing Doctor of Philosophy in Leadership and Doctor of ... campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor of Nursing Practice ... the highest level of clinical nursing practice. , “Our vision is to graduate ...
(Date:8/27/2015)... ... ... Hospital North Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open a ... be located at US Highway 19 North and Highlands Boulevard, less than eight miles from ... the project is slated to begin in September 2015. , The new 24-bed ...
(Date:8/27/2015)... ... August 27, 2015 , ... NetDimensions is once again named ... the platforms required not only to effectively deliver, curate and administer great programs, but ... Inc. , For six consecutive years, NetDimensions has maintained its position on this ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3
... estimate that fully 95 percent of our DNA represents ... the journal Cell researchers at The Wistar ... the discovery of the ability of long non-coding RNA ... long ncRNA molecules may represent so-called gene enhancer elementsshort ...
... used as a marker of health and well-being in unborn ... currently available to differentiate between a small, healthy fetus and ... significant limitations. What if they were improved? Would it save ... need medical intervention because their fetuses might just be small ...
... Fox Foundation for Parkinson,s Research announced awards totaling approximately ... pre-clinical therapeutic development projects. The funding includes $2.5 million ... Intervention Awards, one of the Foundation,s Edmond J. Safra ... the 2010 Clinical Intervention Awards are: , Charlotte ...
... Oct. 6, 2010 A set of proteins found ... way to diagnose Alzheimer,s disease, researchers at UT Southwestern Medical ... An analysis of the proteins, plus a clinical exam, ... percent accurate in ruling it out in people without the ...
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) -- ... received ,hands-only, cardiopulmonary resuscitation (CPR) from a bystander were ... received no CPR or conventional CPR with mouth-to-mouth breathing. ... only is ,hands-only, CPR -- in which the rescuer ...
... Mozes HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay ... apnea can subtly alter the shape of a patient,s face ... treatment, called continuous positive airway pressure (CPAP) can help relieve ... found possible craniofacial change [as a result of] long-term CPAP ...
Cached Medicine News:Health News:Wistar researchers discover new class of objects encoded within the genome 2Health News:Wistar researchers discover new class of objects encoded within the genome 3Health News:MFM researcher earns $3.7M NIH grant to study preterm birth 2Health News:MJFF announces over $10 million in funding for clinical and pre-clinical PD research 2Health News:Blood test could diagnose Alzheimer's disease, UT Southwestern researchers find 2Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 2Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 3Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 4Health News:Sleep Apnea Mask May Cause Subtle Facial Changes 2Health News:Sleep Apnea Mask May Cause Subtle Facial Changes 3
... and negative whole blood control to test ... solubility tests and hemoglobin electrophoresis. Sickle-Chex is ... manufacturers' solubility kits. Sickle-Chex is packaged in ... vial dispenses an accurate sample volume. No ...
... three-part differential control assayed for all parameters on ... Series, AcT/AcT diff/AcT diff2, MD Series and ONYX ... 1800; ABX Micros 60; and Diatron Abacus and ... stability of 30 days and a six-month closed-vial ...
... Cell-Chex Auto is a whole blood ... of hematology instruments that measure automated blood ... The assay provides total RBC and WBC ... and Sapphire, Beckman Coulter LH750/LH 755 (levels ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Medicine Products: